Agios Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 47.16. In total, the insiders bought 697 857 and sold 270 216 AGIO shares in the last 100 trades.

Insider Power

(Last 100 transactions)
47.16
Buy 697 857 Shares
Sell 270 216 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 13, 2025 Common stock Buy Capello Jeffrey D 1 977
Jun 13, 2025 Restricted stock units Sell Capello Jeffrey D 1 977
Jun 13, 2025 Common stock Buy Owen Adams Catherine 1 977
Jun 13, 2025 Restricted stock units Sell Owen Adams Catherine 1 977
Apr 10, 2025 Common stock Sell Fouse Jacqualyn A 7 497
Apr 08, 2025 Common stock Buy Fouse Jacqualyn A 15 933
Apr 08, 2025 Restricted stock units Sell Fouse Jacqualyn A 15 933
Mar 05, 2025 Stock options (right to buy) Buy Viswanadhan Krishnan 55 374
Mar 05, 2025 Restricted stock units Buy Viswanadhan Krishnan 24 300
Mar 05, 2025 Buy Viswanadhan Krishnan 0
Mar 03, 2025 Common stock Sell Burns James William 1 681
Mar 03, 2025 Common stock Sell Burns James William 1 187
Mar 03, 2025 Common stock Sell Burns James William 1 137
Mar 03, 2025 Common stock Sell Jones Cecilia 1 681
Mar 03, 2025 Common stock Sell Jones Cecilia 594
Mar 03, 2025 Common stock Sell Milanova Tsveta 1 681
Mar 03, 2025 Common stock Sell Goff Brian 8 794
Mar 03, 2025 Common stock Sell Goff Brian 4 153
Mar 03, 2025 Common stock Sell Gheuens Sarah 1 681
Mar 03, 2025 Common stock Sell Gheuens Sarah 1 187
Mar 03, 2025 Common stock Sell Gheuens Sarah 1 137
Mar 03, 2025 Common stock Sell Washburn Theodore James Jr. 727
Mar 03, 2025 Common stock Sell Washburn Theodore James Jr. 697
Mar 03, 2025 Common stock Sell Washburn Theodore James Jr. 231
Mar 03, 2025 Restricted stock units Sell Washburn Theodore James Jr. 2 450
Click to get the best stock tips daily for free!
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
1.78% Jun 02
TAC
$8.90
27.87% May 12
UAA
$5.84
5.65% May 09
MEDP
$300.81
0.625% May 08
P
PENG
$17.23
14.80% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE